Lv4
490 积分 2024-01-20 加入
Efficacy and Safety of Fuzheng Jiedu Xiaoji Formula Combined with Conventional Western Therapy in Advanced HBV-HCC: A Single-Center, Randomized Controlled Trial
3天前
已完结
Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure
2个月前
已关闭
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score
2个月前
已关闭
Combination locoregional and systemic therapies in hepatocellular carcinoma
5个月前
已完结
Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study
5个月前
已完结
RISK FACTORS AND PROFILE OF MALIGNANT PORTAL VEIN THROMBOSIS IN HEPATOCELLULAR CARCINOMA
6个月前
已完结
Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients
6个月前
已完结
Microscopic Portal Vein Invasion in Relation to Tumor Focality and Dimension in Patients with Hepatocellular Carcinoma
6个月前
已关闭
A study of the clinical profile, predictors, prognostic features, and survival of patients with hepatocellular carcinoma having macroscopic portal vein tumor thrombosis
6个月前
已完结
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
6个月前
已完结
皖公网安备34019202002308
